We are using cookies This website uses cookies in order to offer you the most relevant information. By browsing this website, you accept these cookies.
Usage of adenocarcinoma of the esophagus in anglès
1
Incidence rates for adenocarcinomaoftheesophagus and gastric cardia have been rising rapidly.
2
Methods and materials: Patients with adenocarcinomaoftheesophagus without distant organ metastases were eligible.
3
Incidence increased for several cancers, including pancreas, kidney, and adenocarcinomaoftheesophagus, which are associated with excess weight.
4
Patients and methods: Sixty-one patients with advanced, surgically unresectable, or metastatic squamous cell or adenocarcinomaoftheesophagus were treated.
5
A retrospective analysis should compare the two operative approaches, transhiatal or transthoracic resection in patients suffering from adenocarcinomaoftheesophagus.
6
Introduction: Even after potentially curative esophagectomy, the majority of patients with adenocarcinomaoftheesophagus or gastroesophageal junction die due to cancer recurrence.
7
Conclusions: There were significant differences in the gene profile between patients with adenocarcinomaoftheesophagus responding to neoadjuvant chemotherapy compared with nonresponding patients.
8
In summary, tumor uPA content as determined by ELISA appears to be a powerful, independent prognostic factor for survival in adenocarcinomaoftheesophagus.
9
Results: Compared to nonneoplastic epithelium, there was a significant increase in YAP cytoplasmic and nuclear localization in high-grade dysplastic epithelium and adenocarcinomaoftheesophagus.
10
Results: The median follow-up time for 518 patients was 29.3 months (range 1-149.2); all patients had adenocarcinomaoftheesophagus.
11
Adenocarcinomaoftheesophagus and gastroesophageal junction (GEJ) has shown a remarkable increase during recent decades.
12
Adenocarcinomaoftheesophagus continues to increase in incidence and has become a significant health problem in Western countries.